Article
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.
Leukemia - 1 Feb 2016
Larrayoz M, Blakemore S J, Dobson R C, Blunt M D, Rose-Zerilli M J J, Walewska R, Duncombe A, Oscier D, Koide K, Forconi F, Packham G, Yoshida M, Cragg M S, Strefford J C, Steele A J
Abstract excerpt
The pro-survival Bcl-2 family member Mcl-1 is expressed in chronic lymphocytic leukaemia (CLL), with high expression correlated with progressive disease. The spliceosome inhibitor spliceostatin A (SSA) is known to regulate Mcl-1 and so here we assessed the ability of SSA to elicit apoptosis in CLL. SSA induced apoptosis of CLL cells at low nanomolar concentrations in a dose- and time-dependent manner, but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
